Stocklytics Platform
Asset logo for symbol RPRX
Royalty Pharma PLC
RPRX51
$27.74arrow_drop_down0.01%-$0.00
Asset logo for symbol RPRX
RPRX51

$27.74

arrow_drop_down0.01%

Income Statement (RPRX)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT-$290.37M-$803.54M$611.58M$166.53M$274.69M
EBITDA$269.63M-$73.77M$613.00M$167.94M$274.81M
gross Profit$531.26M-$15.62M$519.48M$259.17M$296.97M
NET Income$102.00M$4.77M$494.34M$72.11M$227.62M
total Revenue$537.26M$567.97M$596.00M$536.31M$538.20M

Balance Sheet (RPRX)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt$5.83B$5.29B$5.65B$5.19B$4.95B
stockholders Equity$6.47B$6.49B$6.52B$6.13B$6.28B
total Assets$17.65B$16.13B$16.38B$15.85B$17.12B
total Debt$7.60B$6.13B$6.13B$6.13B$7.12B
total Liabilities$7.90B$6.26B$6.29B$6.27B$7.30B

Cash Flow (RPRX)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow$1.15B-$213.42M-$237.97M-$1.35B-$346.99M
free Cash Flow-$84.47M$583.51M-$224.95M$573.52M$607.81M
investing Cash Flow-----$63.43M
operating Cash Flow$662.15M$669.60M$777.28M$573.52M$607.81M

Royalty Pharma PLC (RPRX) Financials

The income statement for Royalty Pharma PLC (RPRX) provides a snapshot of the company's financial performance. It shows the revenue generated from its operations and the expenses incurred to generate that revenue. The income statement also includes key measures such as EBIT (Earnings Before Interest and Taxes) and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). EBIT represents the company's operating income before deducting interest and taxes, while EBITDA adds back non-cash expenses like depreciation and amortization. These measures help assess the company's profitability and operating efficiency.
Another important figure on the income statement is the gross profit, which is the revenue minus the cost of goods sold. It indicates how much profit the company makes from its core operations. The net income from stockholders represents the profit that is attributable to the company's shareholders after deducting taxes and other expenses. Overall, the income statement provides a comprehensive view of the company's earnings, expenses, and profitability.
add Royalty Pharma PLC to watchlist

Keep an eye on Royalty Pharma PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media